Objective
To establish whether nimodipine, a calcium channel blocker, accelerates or otherwise improves functional recovery of whisking after facial nerve crush injury in the rat.
Methods
Thirty rats underwent exposure of the left main trunk of the facial nerve followed by a standard crush injury, and subsequent quantitative facial movement testing. Animals were randomized into an experimental group (n=15) and a control group (n=15 each). Four days prior to facial nerve manipulation, experimental animals underwent subcutaneous implantation of a nimodipine-secreting pellet. All animals were tested pre-operatively and on post-crush days 2, 8–17, 20, 22, 24, and 31, using a validated, quantitative whisking kinematics apparatus. Whisks were analyzed for amplitude, velocity, and acceleration.
Results
Animals receiving nimodipine demonstrated significantly better whisking on days 9, 11–13, and 20 compared with control animals (p<.05). Overall, the nimodipine-treated animals showed earlier recovery as compared to the untreated animals.
Conclusions
We demonstrate that nimodipine improves recovery of whisking after facial nerve crush. This finding corroborates the semi-quantitative findings of others, and provides complete whisking kinematic data on its effects. Given the low side effect profile of nimodipine, there may be clinical implications in its administration in patients experiencing facial nerve injury.